1Pharmacological and clinical evaluation of afatinib for the treatment of NSCLCHUO Xiu-ying, FENG Yu-fei1473-14762Quality system for security of drug quality control data in laboratory computersLI Jian, XIANG Xin-hua, CHEN Wei1477-14833Discussion on the countermeasure to the drug emergency inspection managementLIN Lan, GAO Zhi-feng1484-14864Analysis of main problems for CMC changes of the post-approval chemical drugsYANG Jian-hong1487-1492,15245Determination of lysolipid in vinorelbine liposome for injection by HPLC-charged aerosol detectorLI Han, GONG Wei, ZHANG Hui, MEI Xing-guo1493-14966UPLC determination of ginsenoside Rh1 and Rh2 in secondary ginsenoside H dripping pillZHOU Hong-yu, WANG Yu, SONG Zhao-hui, ZHANG Lan-lan, ZHOU Shui-ping, FENG Feng1497-15007Main points and inspirations of guidance for bioequivalence studies of oral solid products in European and American countriesZHANG Yi-fan, ZHONG Da-fang1501-15058GastroPlus simulation technology for evaluating the bioequivalence of cefdinir capsulesPAN Rui-xue, YU Fang-jian, ZOU Wen-bo, HU Chang-qin1506-15139U.S.FDA drug safety information communication platform and drug quality reporting systemGeorge R.Bolger, TU Yong-rui, SUN Pei-hua, XIE Guo-wei, QIAO Wei-dong, ZHANG Hong1514-152010Preparation and comparison of concealment allocation methods of alternative vaccine in double-blinded clinical vaccine trialsKONG Yu-jia, WANG Ling, JIANG Zhi-wei, LI Chan-juan, XIA Jie-lai1521-152411Advances in research of recombinant human endostatin (Endostar) in the treatment of lung cancerLUO Xing-hong, ZHAO Yan, QIAN Hai-bo, QIN Shu-kui1525-153112Progress towards the clinical application of class Ⅲ antiarrhythmic agents for controlling perioperative rapid ventricular rate of atrial fibrillationZONG Ya-nan, ZHANG Li-ping1532-1535,154513Hemocidins: a new type of antimicrobial peptides derived from hemoproteinsCHEN Xiang, NIU Rong-li1536-1539,155614Photodynamic therapy for cancer treatment and the new antitumor photosensitizer sinoporphyrin sodiumFANG Qi-cheng1540-154515Construction of quality control system in clinical anti-tumor drug trialsZHAO Shu-hua, JIANG Min1546-154816Methods for the prediction of maximum recommended first-in-human starting doseWEI Min-ji, HOU Jie, ZHAO Cai-yun, L(U) Yuan1549-155217Status and duties of clinical research nurseJIN Yan, ZHANG Qing-yuan, ZHANG Guo-li, GUO Li-bo, YUAN Li-jie1553-155618Analysis of efficacy and influencing factors of icotinib hydrochloride for the treatment of pretreated advanced non-small cell lung cancer1557-156119Determination of oil/water partition coefficient of rasagiline mesylateSUN Yong-qiang, YAN Yi-min, TU Yong-rui, FENG Xiao-hui, JIANG Wei, WANG Ju-xiang, QI Qi1562-1564,157320Predicting nephrotoxicity of drugs using mathematical modelsWANG Xin-zhou, ZHU Yong-liang, JIN Ruo-min, LIU Jing-ge, QIAN Xiang-ping, YAO Guang-tao, YE Zu-guang1565-1568,1578 